Evidence-based medicine for thromboprophylaxis in hospitalized patients with cancer: Why aren't we there yet?

Journal of Clinical Oncology

Volumn 32, Issue 17, 2014, Pages 1754-1756

  Lee, Agnes Y Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN;

ANTICOAGULATION; BLEEDING; CANCER CHEMOTHERAPY; CROSS-SECTIONAL STUDY; EDITORIAL; EVIDENCE BASED MEDICINE; HEMATOLOGIC MALIGNANCY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS (TOPIC); MORTALITY; PATIENT; PATIENT CARE; PATIENT COMFORT; PATIENT SELECTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS PREVENTION; UNITED STATES; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; FEMALE; HUMANS; MALE; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; THROMBOEMBOLISM;

EID: 84905861073     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.4980     Document Type: Editorial

References (18)

1. Elting LS, Escalante CP, Cooksley C, et al: Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med 164:1653-1661, 2004 (Pubitemid 39037944)
2. Burleigh E, Wang C, Foster D, et al: Thromboprophylaxis in medically ill patients at risk for venous thromboembolism. Am J Health Syst Pharm 63:S23-S29, 2006 (Pubitemid 44672126)
3. Amin AN, Stemkowski S, Lin J, et al: Inpatient thromboprophylaxis use in U.S. hospitals: Adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients. J Hosp Med 4:E15-E21, 2009
4. Zwicker JI, Rojan A, Campigotto F, et al: Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: A prospective, cross-sectional, multicenter study. J Clin Oncol 32:1792-1796, 2014
5. Alikhan R, Cohen AT, Combe S, et al: Prevention of venous thromboembolism in medical patients with enoxaparin: A subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 14:341-346, 2003 (Pubitemid 36688187)
6. Carrier M, Khorana AA, Moretto P, et al: Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer. Am J Med 127:82-86, 2014
7. Kahn SR, Lim W, Dunn AS, et al: Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e195S-e226S, 2012
8. Lyman GH, Khorana AA, Kuderer NM, et al: Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2189-2204, 2013
9. Barbar S, Noventa F, Rossetto V, et al: A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: The Padua Prediction Score. J Thromb Haemost 8:2450-2457, 2010
10. Vardi M, Ghanem-Zoubi NO, Zidan R, et al: Venous thromboembolism and the utility of the Padua Prediction Score in patients with sepsis admitted to internal medicine departments. J Thromb Haemost 11:467-473, 2013
11. Blom JW, Doggen CJ, Osanto S, et al: Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293:715-722, 2005 (Pubitemid 40216041)
12. Khorana AA, Francis CW, Culakova E, et al: Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110:2339-2346, 2007 (Pubitemid 350100757)
13. Cohen AT, Spiro TE, Spyropoulos AC: Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 368:1945-1946, 2013
14. Prandoni P, Lensing AW, Piccioli A, et al: Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100:3484-3488, 2002 (Pubitemid 35303914)
15. Goldhaber SZ, Leizorovicz A, Kakkar AK, et al: Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 365:2167-2177, 2011
16. Spencer FA, Lessard D, Emery C, et al: Venous thromboembolism in the outpatient setting. Arch Intern Med 167:1471-1475, 2007 (Pubitemid 47124177)
17. White RH, Zhou H, Murin S, et al: Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 93:298-305, 2005 (Pubitemid 40253735)
18. Khorana AA, Francis CW, Culakova E, et al: Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 24:484-490, 2006 (Pubitemid 46630468)